Neuphoria Therapeutics Inc. Form DEFA14A: Additional definitive proxy soliciting materials
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-18: Form DEFA14A; Description DEFA14A; Document ny20081637x2_defa14a.htm.
- 2026-09-18: Form DEFA14A; Description DEFA14A; Document ny20081637x2_defa14a.htm.
- 2026-07-24: Form DEFA14A; Description CURRENT REPORT; Document ea0298914-8k_neuphoria.htm.
- 2025-12-08: Form DEFA14A; Description DEFINITIVE ADDITIONAL MATERIALS; Document ea0268814-defa14a_neuphoria.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-09-18 | DEFA14A | DEFA14A | ny20081637x2_defa14a.htm | |
| 2026-09-18 | DEFA14A | DEFA14A | ny20081637x2_defa14a.htm | |
| 2026-07-24 | DEFA14A | CURRENT REPORT | ea0298914-8k_neuphoria.htm | |
| 2025-12-08 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea0268814-defa14a_neuphoria.htm | |
| 2025-12-04 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea0268549-defa14a_neuphoria.htm | |
| 2025-12-01 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea0267840-defa14a_neu.htm | |
| 2025-11-25 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea0267133-defa14a_neuphoria.htm | |
| 2025-11-24 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea0266948-defa14a_neuphoria.htm | |
| 2025-11-12 | DEFA14A | SOLICITING MATERIAL UNDER 240. RULE 14A-12 | ea0265148-defa14a_neuphoria.htm | |
| 2025-10-30 | DEFA14A | DEFA14A | ny20055722x2_defa14a.htm | |
| 2024-11-13 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | ea0221134-defa14a_bionomics.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |